Impact of delay due to the first wave of the COVID-19 pandemic on elective surgical patients in a tertiary care center: a prospective observational study
DOI:
https://doi.org/10.18203/2349-2902.isj20231387Keywords:
COVID-19, Elective surgical procedures, Breast neoplasms, Gastrointestinal neoplasms, Delivery of health careAbstract
Background: Elective services were withheld in most parts of the world to cope with the stress on the healthcare system caused by the Coronavirus disease 2019 (COVID-19). However, delaying elective services for more than a particular duration adversely affects disease outcomes. This study aimed to assess the effect on elective surgical patients due to delays caused by withholding elective surgical services to deal with the COVID-19 pandemic at our institution.
Methods: This prospective observational study included all the patients who planned and waited for elective surgery till the day elective services were withheld at our institution (24 March 2020) due to the COVID-19 pandemic. All patients were followed until the patients were operated on or three months after resuming elective operative services at our institution. These patients were assessed to determine the proportion of patients with worsening symptoms, stage progression, and needing emergency procedures or palliative surgery.
Results: Breast cancer was the most common cancer among malignancy patients awaiting surgery. Compared to Breast cancer, Gastrointestinal cancers had a significantly higher proportion of patients with stage progression (61.3% vs. 90%, p=0.016) and mortality (6.5% vs. 53.3%, p<0.001). In benign patients, symptom progression was seen in 45.9%, and emergency surgery/procedures were needed in 5.4 %.
Conclusions: Even though the so-called elective surgery, postponing these surgeries, particularly cancer surgeries, can compromise the outcomes of the patients if delayed for more than a certain point.
Metrics
References
Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SL, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020;395:949-50.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579: 270-3.
Stahel PF. How to risk-stratify elective surgery during the COVID-19 pandemic? Patient Saf Surg. 2020;14: 8.
Myles PS, Maswime S. Mitigating the risks of surgery during the COVID-19 pandemic. Lancet. 2020;396:2-3.
Godman B. Combating COVID-19: Lessons learnt particularly among developing countries and the implications. Bangladesh J Med Sci. 2020;19:S103-8.
Zahra W, Dixon JW, Mirtorabi N, Rolton DJ, Tayton ER, Hale PC, et al. Safety evaluation of a strategy to restart elective orthopaedic surgery during the de-escalation phase of the COVID-19 pandemic. Bone Joint. 2020;1:450-6.
Mavioğlu HL, Ünal EU, Aşkın G, Küçüker ŞA, Özatik MA. Perioperative planning for cardiovascular operations in the COVID-19 pandemic. Turk J Thorac Cardiovasc. 2020;28:236.
Givi B, Schiff BA, Chinn SB, Clayburgh D, Iyer NG, Jalisi S, et al. Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic. JAMA Otolaryngol Head Neck Surg. 2020;146:579-84.
Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto JW, et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol. 2020;77:663-6.
Nepogodiev D, Bhangu A, Glasbey JC, Li E, Omar OM, Simoes JF, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396:27-38.
Iacobucci G. How is the pandemic affecting non-covid services? BMJ. 2021;5:372.
Omar OM, Simoes JF. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020;107:1440-9.
Fligor SC, Wang S, Allar BG, Tsikis ST, Ore AS, Whitlock AE, et al. Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery. J Gastrointest Surg. 2020;24:2357-73.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality orldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49.
Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Nat Cancer Inst Monograph. 2014;2014: 187-97.
Smith SM, Wachter K, Burris III HA, Schilsky RL, George DJ, Peterson DE, et al. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. J Clin Oncol. 2021;39:1165-84.
Jonker PK, Van der Plas WY, Poelstra R, Emous M, Van der Meij W et al. Dutch Surgical COVID-19 Research Collaborative. Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study. Surgery. 2021;169:264-74.
Kibbe MR. Surgery and COVID-19. JAMA. 2020; 324:1151-2.
Glasbey JC, Nepogodiev D, Simoes JF, Omar O, Li E, Venn ML, et al. Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study. J Clin Oncol. 2021;39:66-78.
Shaw R, Winter SC, Glasbey J, Ho MW, Jackson R. Head and neck cancer surgery during the COVID‐19 pandemic: an international, multicenter, observational cohort study. Cancer. 2021;127:2476-88.
Kumar D, Dey T. Treatment delays in oncology patients during COVID-19 pandemic: A perspective. J Glob Health. 2020;10.
